Moreover, these results demonstrate that LAT1 may be a predictor of clinical prognosis in breast cancer patients as well as a predictive factor of the therapeutic efficacy of preoperative and postoperative chemotherapy. The gene discussed is SLC7A5; the disease is breast cancer.